Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 5
1986 6
1987 7
1988 1
1990 1
1992 1
1993 1
1994 4
1995 5
1996 4
1997 10
1998 11
1999 10
2000 8
2001 6
2002 8
2003 4
2004 3
2005 3
2006 5
2007 4
2008 3
2009 6
2010 17
2011 12
2012 12
2013 13
2014 10
2015 16
2016 12
2017 25
2018 20
2019 23
2020 16
2021 13
2022 6
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Hosokawa M, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H. Imamura K, et al. Among authors: tamaoka a. Sci Transl Med. 2017 May 24;9(391):eaaf3962. doi: 10.1126/scitranslmed.aaf3962. Sci Transl Med. 2017. PMID: 28539470 Free article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. Among authors: tamaoka a. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
[Dyslipidemia and Dementia].
Tamaoka A. Tamaoka A. Brain Nerve. 2016 Jul;68(7):737-42. doi: 10.11477/mf.1416200505. Brain Nerve. 2016. PMID: 27395458 Japanese.
Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).
Nakajima T, Sankai Y, Takata S, Kobayashi Y, Ando Y, Nakagawa M, Saito T, Saito K, Ishida C, Tamaoka A, Saotome T, Ikai T, Endo H, Ishii K, Morita M, Maeno T, Komai K, Ikeda T, Ishikawa Y, Maeshima S, Aoki M, Ito M, Mima T, Miura T, Matsuda J, Kawaguchi Y, Hayashi T, Shingu M, Kawamoto H. Nakajima T, et al. Among authors: tamaoka a. Orphanet J Rare Dis. 2021 Jul 7;16(1):304. doi: 10.1186/s13023-021-01928-9. Orphanet J Rare Dis. 2021. PMID: 34233722 Free PMC article. Clinical Trial.
[Dementia and dyslipidemia].
Tamaoka A. Tamaoka A. Nihon Ronen Igakkai Zasshi. 2011;48(2):114-7. doi: 10.3143/geriatrics.48.114. Nihon Ronen Igakkai Zasshi. 2011. PMID: 21778621 Free article. Review. Japanese. No abstract available.
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N. Ichimura Y, et al. Among authors: tamaoka a. Rheumatology (Oxford). 2022 Mar 2;61(3):1222-1227. doi: 10.1093/rheumatology/keab518. Rheumatology (Oxford). 2022. PMID: 34152410
Dentatorubropallidoluysian Atrophy with Prominent Autonomic Dysfunction.
Shioya A, Takuma H, Ohkoshi N, Hirano K, Ishihara T, Ishii K, Tamaoka A. Shioya A, et al. Among authors: tamaoka a. Intern Med. 2023 Mar 15;62(6):889-892. doi: 10.2169/internalmedicine.9616-22. Epub 2022 Aug 20. Intern Med. 2023. PMID: 35989279 Free PMC article.
Clinical features of drug-induced Parkinsonism.
Shiraiwa N, Tamaoka A, Ohkoshi N. Shiraiwa N, et al. Among authors: tamaoka a. Neurol Int. 2018 Dec 20;10(4):7877. doi: 10.4081/ni.2018.7877. eCollection 2018 Dec 5. Neurol Int. 2018. PMID: 30687468 Free PMC article.
290 results